Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis,

Technology advancements, portability, and fusion technology applications are expected to drive the global medical equipment industry. The industry experienced average growth over the last five years and is expected to reach approximately US $93.6 billion in 2017 with a CAGR of 4.1% over the next five years.

Lucint

el, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical equipment companies and presents its findings in “Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The global medical equipment market consists of the total revenues generated through ophthalmic equipment such as retinal cameras and ophthalmoscopes; in vitro diagnostic such as clinical diagnostic and immunoassay; diagnostic imaging equipment including X-ray, MRI, CT scan, and ultrasound; and dental equipment. In this study, Lucintel profiles the following five companies with detailed competitive assessments:
 

                                              
As per the study, dental equipment was the fastest-growing segment during 2006-2011 as introduction of CAD/CAM systems and laser technology resulted in cost effectiveness and better performance. The proportion of people over 65 years of age is increasing globally, enhancing the propensity of tooth replacement. Asia Pacific is currently a developing region and with improvement in economy, there is good growth potential in future. Governments in many Asian countries are ramping up efforts to increase medical insurance coverage and establish more hospitals

This study is intended to provide industry leaders with a competitive benchmarking of the world’s top five medical equipment companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of an effective marketing and sales plan.

Medical equipment companies competitive analysis report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical equipment companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business

In Lucintel's newest competitive research study on the world's medical equipment companies, we thoroughly profile following five companies with detailed competitive assessments:
 

The detailed analysis of each company offers a critical view into key strategic areas, including:

To make any investment, business or strategic decisions, you need adequate and timely information. Medical equipment companies competitive analysis market report fulfills this core need. This is an indispensable reference guide for industry executives who are dealing with medical equipment companies industry.

Some of the features of Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis market intelligence report are:

List of Figures

 

CHAPTER 3. Market Opportunity

Figure 3.1: Supply chain for medical equipment market

Figure 3.2: Global medical equipment industry annual trend 2006-2011 (US $B)

Figure 3.3: Global medical equipment industry regional trend 2006-2011 (US $B)

Figure 3.4: Global medical equipment industry regional trend 2006-2011 (%)

Figure 3.5: Global medical equipment industry segment trend 2006-2011 (US $B)

Figure 3.6: Global medical equipment industry segment trend 2006-2011 (%)

Figure 3.7: Global medical equipment industry opportunity by region

Figure 3.8: Global medical equipment industry opportunity by segment

    

CHAPTER 4.Competitive Benchmarking (Financial and Market)

Figure 4.1: Top five medical equipment companies – financial benchmarking

Figure 4.2: Global top five medical equipment companies gross profit and net profit analysis – 2011

Figure 4.3: Financial analysis – growth leadership quadrant (2011)

Figure 4.4: Market share of top players 2006

Figure 4.5: Market share of top players 2011

Figure 4.6: 2006 Market share analysis

Figure 4.7: 2011 Market share analysis

Figure 4.8: Global market share analysis 2011

Figure 4.9: Global market fragmentation 2011  

Figure 4.10: Market value North America: (US $B)

Figure 4.11: Market value Europe (US $B)

Figure 4.12: Market value Asia Pacific (US $B)

Figure 4.13: Market value Row (US $B)

Figure 4.14: Regional revenue evaluation 2011(US $M)

Figure 4.15: Regional revenue evaluation 2011(%)

Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)

Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)

Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)

Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)

Figure 4.20: Lucintel triad - top five major players

 

CHAPTER 5. Company Profile of Abbott

Figure 5.1: Abbott’s revenue by business structure 2011

Figure 5.2: Lucintel Triad – Abbott

Figure 5.3: Financial benchmarking Abbott against top three and top five industry players’ average

Figure 5.4: Financial benchmarking of Abbott against Top Five best

Figure 5.5: Global industry revenue trend Vs Abbott (2007-2011) in US $B

Figure 5.6: Global market share trend for Abbott (2007-2011) in (%)

Figure 5.7: North American industry revenue trend Vs. Abbott 2007-2011 in (US $B)

Figure 5.8: European industry revenue trend Vs. Abbott 2007-2011 in (US $B)

Figure 5.9:   APAC industry revenue trend Vs. Abbott 2007-2011 in (US $B)

Figure 5.10: ROW industry revenue trend Vs. Abbott 2007-2011 in (US $B)

Figure 5.11: North American market share trend Vs. Abbott 2007-2011 in (%)

Figure 5.12: European market share trend Vs. Abbott 2007-2011 in (%)

Figure 5.13: APAC market share trend Vs. Abbott 2007-2011 in (%)

Figure 5.14: ROW market share trend Vs. Abbott 2007-2011 in (%)

Figure 5.15: Abbott trend in R&D expenses 2007-2011 in US $M

Figure 5.16: Abbott trend in R&D expenses Percentage of total revenue

Figure 5.17: Comparison of Abbott SE R&D expenditure vs. top three & top five players average 2011

Figure 5.18: Abbott productivity 2007-2011 (US $M)

Figure 5.19: Abbott capital investment value 2007-2011 (US $M)

Figure 5.20: Strategic execution

 

CHAPTER 6. Company Profile of General Electric

Figure 6.1: General Electric revenue by business structure 2011

Figure 6.2: Lucintel triad - General Electric

Figure 6.3: Financial benchmarking of General Electric against top three and top five industry players’ average

Figure 6.4: Financial benchmarking of General Electric against Top five best

Figure 6.5: Global industry revenue trend Vs. General Electric (2007-2011) in (US $B)

Figure 6.6: Global market share trend for General Electric (2007-2011) in (%)

Figure 6.7: North American industry revenue trend Vs. General Electric 2007-2011 in (US $B)

Figure 6.8: European industry revenue trend Vs. General Electric 2007-2011 in (US $B)

Figure 6.9: APAC industry revenue trend Vs. General Electric 2007-2011 in (US $B)

Figure 6.10: ROW industry revenue trend Vs. General Electric 2007-2011 in (US $B)

Figure 6.11: North American market share trend Vs. General Electric 2007-2011 in (%)

Figure 6.12: European market share trend Vs. General Electric 2007-2011 in (%)

Figure 6.13: APAC market share trend Vs. DuPont 2007-2011 in (%)

Figure 6.14: ROW market share trend Vs. DuPont 2007-2011 in (%)

Figure 6.15: General Electric trend in R&D expenses 2007-2011 in US

Figure 6.16: General Electric trend in R&D expenses Percentage of total revenue

Figure 6.17: Comparison of General Electric SE R&D expenditure vs. top three & top five players average 2011

Figure 6.18: General Electric productivity: 2007-2011 in (US $M)

Figure 6.19: General Electric capital investment value: 2007-2011 in (US $M)

Figure 6.20: Strategic execution

 

CHAPTER 7. Company Profile of Philips

Figure 7.1: Philips revenue by business structure 2011

Figure 7.2: Lucintel triad – Philips

Figure 7.3: Financial benchmarking of Philips against top three and top five industry players’ average

Figure 7.4: Financial benchmarking of Philips against Top five best

Figure 7.5: Global industry revenue trend Vs. Philips (2007-2011) in (US $B)

Figure 7.6: Global market share trend for Philips (2007-2011) in (%)

Figure 7.7: North American industry revenue trend Vs. Philips (2007-2011) in (US $B)

Figure 7.8: European industry revenue trend Vs. Philips l (2007-2011) in(US $B)

Figure 7.9: APAC industry revenue trend Vs. Philips (2007-2011) in (US $B)

Figure 7.10: ROW industry revenue trend Vs. Philips (2007-2011) in (US $B)

Figure 7.11: North American market share trend Vs. Philips (2007-2011) in (%)

Figure 7.12: European market share trend Vs. Philips l (2007-2011) in (%)

Figure 7.13: APAC market share trend Vs. Philips (2007-2011) in (%)

Figure 7.14: ROW market share trend Vs. Philips (2007-2011) in (%)

Figure 7.15: Philips trend in R&D expenses 2007-2011 in US $M

Figure 7.16: Philips trend in R&D expenses Percentage of total revenue

Figure 7.17: Comparison of Philips R&D expenditure vs. top three & top five players average 2011

Figure 7.18: Philips productivity 2007-2011 in (US $M)

Figure 7.19: Philips capital investment value 2007-2011 in (US $M)

Figure 7.20: Strategic execution

 

CHAPTER 8. Company Profile of Roche

Figure 8.1: Roche revenue by business structure 2011

Figure 8.2: Lucintel triad – Roche

Figure 8.3: Financial benchmarking of Roche against top three and top five industry players’ average

Figure 8.4: Financial benchmarking of Roche against Top five best

Figure 8.5: Global industry revenue trend Vs. Roche (2007-2011) in (US $B)

Figure 8.6: Global market share trend for Roche (2007-2011) in (%)

Figure 8.7: North American industry revenue trend Vs. Roche (2007-2011) in (US $B)

Figure 8.8: European industry revenue trend Vs. Roche (2007-2011) in (US $B)

Figure 8.9: APAC industry revenue trend Vs. Roche (2007-2011) in (US $B)

Figure 8.10: ROW industry revenue trend Vs. Roche (2007-2011) in (US $B)

Figure 8.11: North American market share trend Vs. Roche (2007-2011) in (%)

Figure 8.12: European market share trend Vs. Roche (2007-2011) in (%)

Figure 8.13: APAC market share trend Vs. Roche (2007-2011) in (%

Figure 8.14: ROW market share trend Vs. Roche (2007-2011) in (%)

Figure 8.15: Roche trend in R&D expenses 2007-2011 in US $M

Figure 8.16: Roche trend in R&D expenses Percentage of total revenue

Figure 8.17: Comparison of Roche R&D expenditure vs. top three & top five players average 2011

Figure 8.18: Roche productivity: 2007-2011 in (US $M)

Figure 8.19: Roche capital investment value: 2007-2011 in (US $M)

Figure 8.20: Strategic execution

 

CHAPTER 9. Company Profile of Siemens

             Figure 9.1: Siemens revenue by business structure 2011

Figure 9.2: Lucintel triad – Siemens

Figure 9.3: Financial benchmarking of Siemens against top three and top five industry players’ average

Figure 9.4: Financial benchmarking of Siemens against Top five best

Figure 9.5: Global industry revenue trend Vs. Siemens (2007-2011) in (US $B)

Figure 9.6: Global market share trend for Siemens (2007-2011) in (%)

Figure 9.7: North American industry revenue trend Vs. Siemens (2007-2011) in (US $B)

Figure 9.8: European industry revenue trend Vs. Siemens (2007-2011) in (US $B)

Figure 9.9: APAC industry revenue trend Vs. Siemens (2007-2011) in (US $B)

Figure 9.10: ROW industry revenue trend Vs. Siemens (2007-2011) in (US $B)

Figure 9.11: North American market share trend Vs. Siemens (2007-2011) in (%)

Figure 9.12: European market share trend Vs. Siemens (2007-2011) in (%)

Figure 9.13: APAC market share trend Vs. Siemens (2007-2011) in (%)

Figure 9.14: ROW market share trend Vs. Siemens (2007-2011) in (%)

Figure 9.15: Siemens trend in R&D expenses 2007-2011 in US $M

Figure 9.16: Siemens trend in R&D expenses Percentage of total revenue

Figure 9.17: Comparison of IMERYS R&D expenditure Vs. top three & top five players average 2011

Figure 9.18: Siemens productivity 2007-2011 in (US $M)

Figure 9.19: Siemens capital investment value 2007-2011 in (US $M)

Figure 9.20: Strategic execution

 

 

List of Tables

 

CHAPTER 3. Market Opportunity

Table 3.1: Industry parameters of global pulp and paper chemical industry

Table 3.2: Relative market attractiveness by region

Table 3.3: Regional revenue growth rate

Table 3.4: Segment revenue growth rate

 

CHAPTER 4. Competitive Benchmarking (Financial and Market)

Table 4.1: Financial benchmarking of top five global pulp and paper chemical companies

Table 4.2: Key financial parameters for top five pulp and paper chemical companies

Table 4.3: Regional revenue (US $B)

Table 4.4: Regional revenue (%)

Table 4.5: Competitors based on markets served

Table 4.6: Lucintel triad - Top five major players

 

CHAPTER 5. Company Profile of Abbott

Table 5.1:  Market served: Abbott

Table 5.2:  Lucintel triad – Abbott

Table 5.3:  Financial Benchmarking of Abbott against best and against Top three and Top five industry players’ average

Table 5.4:  Strategic execution – product positioning by segment

Table 5.5:  Strategic execution – perceived customer value / quality

Table 5.6:  Strategic execution – promotion / communications

Table 5.7:  Strategic execution – product distribution by region

 

CHAPTER 6. Company Profile of General Electric  

Table 6.1: Market served – General Electric  

Table 6.2: Lucintel triad – General Electric  

Table 6.3: Financial benchmarking of General Electric against   best and against Top three and Top five industry players’ average

Table 6.4: Strategic execution – product positioning by segment

Table 6.5: Strategic execution – perceived customer value / quality

Table 6.6: Strategic execution – promotion / communications

Table 6.7: Strategic execution – product distribution by region

 

CHAPTER 7. Company Profile of Philips

Table 7.1: Market served – Philips

Table 7.2: Lucintel triad – Philips

Table 7.3: Financial benchmarking of Philips against best and against Top three and Top five industry players’ average

Table 7.4: Strategic execution – product positioning by segment

Table 7.5: Strategic execution – perceived customer value / quality

Table 7.6: Strategic execution – promotion / communications

Table 7.7: Strategic execution – product distribution by region

 

CHAPTER 8. Company Profile of Roche

Table 8.1: Market served – Roche

Table 8.2: Lucintel triad – Roche

Table 8.3: Financial Benchmarking of Roche against best and against Top three and top five industry players’ average

Table 8.4: Strategic execution – product positioning by segment

Table 8.5: Strategic execution – perceived customer value / quality

Table 8.6: Strategic execution – promotion / communications

Table 8.7: Strategic execution – product distribution by region

 

CHAPTER 9. Company Profile of Siemens

Table 9.1: Markets served – Siemens

Table 9.2: Lucintel triad – Siemens

Table 9.3: Financial Benchmarking of Siemens against best and against Top three and top five industry players’ average

Table 9.4: Strategic execution – product positioning by segment

Table 9.5: Strategic execution – perceived customer value / quality

Table 9.6: Strategic execution – promotion / communications

Table 9.7: Strategic execution – product distribution by region